170 related articles for article (PubMed ID: 22451319)
1. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease.
Mlynárik V; Cacquevel M; Sun-Reimer L; Janssens S; Cudalbu C; Lei H; Schneider BL; Aebischer P; Gruetter R
J Alzheimers Dis; 2012; 31 Suppl 3():S87-99. PubMed ID: 22451319
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
3. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
4. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
6. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy.
van Duijn S; Nabuurs RJ; van Duinen SG; Natté R; van Buchem MA; Alia A
J Alzheimers Dis; 2013; 34(4):1051-9. PubMed ID: 23321522
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
[TBL] [Abstract][Full Text] [Related]
10. High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.
Bartha R; Smith M; Rupsingh R; Rylett J; Wells JL; Borrie MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):786-93. PubMed ID: 18252268
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
12. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
[TBL] [Abstract][Full Text] [Related]
13. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
14. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.
Schott JM; Frost C; MacManus DG; Ibrahim F; Waldman AD; Fox NC
Brain; 2010 Nov; 133(11):3315-22. PubMed ID: 20739347
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
16. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2010; 30(1):71-7. PubMed ID: 20689286
[TBL] [Abstract][Full Text] [Related]
17. Effects of short-term stress-like cortisol on cerebral metabolism: a proton magnetic resonance spectroscopy study at 3.0 T.
Scheel M; Ströhle A; Bruhn H
J Psychiatr Res; 2010 Jun; 44(8):521-6. PubMed ID: 20022344
[TBL] [Abstract][Full Text] [Related]
18. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
19. Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease.
Labak M; Foniok T; Kirk D; Rushforth D; Tomanek B; Jasiński A; Grieb P
Acta Neurochir Suppl; 2010; 106():177-81. PubMed ID: 19812944
[TBL] [Abstract][Full Text] [Related]
20. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study.
in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A
J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]